Key regions: Australia, United States, India, Europe, China
The Digestive & Intestinal Remedies (Pharmacies) market in CIS is experiencing steady growth, driven by changing customer preferences and the presence of local special circumstances. Customers in the region are increasingly seeking digestive and intestinal remedies to address common health issues, leading to a rise in demand. Additionally, several local factors are contributing to the development of the market.
Customer preferences: Customers in the CIS region are becoming more health-conscious and are actively seeking remedies for digestive and intestinal issues. This shift in preferences can be attributed to factors such as changing lifestyles, unhealthy eating habits, and increased awareness about the importance of gut health. As a result, there is a growing demand for over-the-counter digestive and intestinal remedies in pharmacies.
Trends in the market: One of the key trends in the Digestive & Intestinal Remedies (Pharmacies) market in CIS is the increasing popularity of natural and herbal remedies. Customers are gravitating towards products that are perceived to be more natural and have fewer side effects. This trend is driving the demand for herbal supplements, probiotics, and other natural remedies for digestive and intestinal health. Another trend in the market is the growing preference for convenience. Customers are looking for easily accessible remedies that can be purchased from their local pharmacies. This has led to an increase in the availability of digestive and intestinal remedies in pharmacies across the CIS region. Pharmacies are expanding their product offerings to cater to this demand, providing customers with a wide range of options to choose from.
Local special circumstances: The CIS region has a unique set of circumstances that contribute to the development of the Digestive & Intestinal Remedies market. One such circumstance is the prevalence of traditional medicine practices. Many countries in the CIS region have a long history of traditional medicine, which includes remedies for digestive and intestinal ailments. This has created a market for traditional remedies alongside modern pharmaceutical products. Additionally, the region's diverse cultural and dietary practices also play a role in shaping customer preferences. Different cuisines and dietary habits can contribute to digestive and intestinal issues, leading to a higher demand for remedies in the market. Local manufacturers and pharmacies are capitalizing on this opportunity by offering products that cater to specific dietary needs and cultural preferences.
Underlying macroeconomic factors: The development of the Digestive & Intestinal Remedies (Pharmacies) market in the CIS region is also influenced by underlying macroeconomic factors. Economic growth and increasing disposable incomes have allowed customers to spend more on healthcare and wellness products. As a result, the demand for digestive and intestinal remedies has risen, driving the growth of the market. Furthermore, the presence of a well-established pharmaceutical industry in the region contributes to the availability and accessibility of digestive and intestinal remedies. Local manufacturers are able to produce and distribute these products efficiently, meeting the growing demand from customers. In conclusion, the Digestive & Intestinal Remedies (Pharmacies) market in the CIS region is developing due to changing customer preferences, local special circumstances, and underlying macroeconomic factors. Customers are increasingly seeking remedies for digestive and intestinal issues, leading to a rise in demand for these products in pharmacies. The market is also influenced by trends such as the popularity of natural and herbal remedies, as well as the preference for convenience. Additionally, local factors such as traditional medicine practices and diverse dietary habits contribute to the development of the market. Overall, the market is driven by the growing health-consciousness of customers and the availability of a wide range of products in pharmacies.
Data coverage:
The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.Modeling approach:
Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.Forecasts:
In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.Additional notes:
The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.
Mon - Fri, 9am - 6pm (EST)
Mon - Fri, 9am - 5pm (SGT)
Mon - Fri, 10:00am - 6:00pm (JST)
Mon - Fri, 9:30am - 5pm (GMT)
Mon - Fri, 9am - 6pm (EST)
